Related Experiment Video

Updated: Jun 18, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Progression of renal dysfunction in patients with cardiovascular disease

Yasunobu Hirata1, Arihiro Kiyosue, Masao Takahashi

  • 1Department of Cardiovascular Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Current Cardiology Reviews
|November 26, 2009
PubMed

Insights

Patients with chronic kidney disease (CKD) experience more cardiovascular events, and cardiovascular diseases (CVD) can worsen kidney damage. Managing shared arteriosclerotic risk factors is crucial for both conditions.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Chronic kidney disease (CKD) is linked to increased cardiovascular events.
  • Cardiovascular diseases (CVD) can exacerbate renal damage, indicating a complex cardiorenal association.
  • Shared arteriosclerotic risk factors play a significant role in the progression of both CKD and CVD.

Purpose of the Study:

  • To highlight the critical interplay between cardiovascular and renal health.
  • To emphasize the importance of managing shared risk factors in cardiorenal disease.
  • To guide treatment strategies for patients with co-existing CKD and CVD.

Main Methods:

  • Review of existing literature on cardiorenal associations.
  • Analysis of the impact of arteriosclerosis on both cardiac and renal systems.
  • Examination of treatment implications for patients with cardiorenal conditions.

Main Results:

  • Arteriosclerosis affects vascular health in both the heart and kidneys.
  • Factors like heart failure and renal dysfunction can accelerate kidney damage.
  • Effective management requires a comprehensive approach to controlling all arteriosclerotic risk factors.

Conclusions:

  • Integrated management of cardiovascular disease (CVD) and chronic kidney disease (CKD) is essential.
  • Treatment selection should prioritize medications with dual cardio-renal protective effects.
  • Strict control of shared risk factors is paramount for improving patient outcomes.

Keywords:
ARBCKDaldosteroneangiotensin IIhypertension.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...